SCHEMBL22721969

SCHEMBL22721969

CCCCOC(=O)N1CC[C@H](N(C)C(=O)OCc2ccccc2)[C@@H](c2ccc(F)cc2C)C1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 2/20 0.43
HTR2A P28223 3/20 0.42
TACR1 P25103 9/20 0.40
CHRM5 P08912 3/20 0.39
CHRM2 P08172 2/20 0.39
CHRM1 P11229 2/20 0.39
CHRM3 P20309 2/20 0.39
HTR1A P08908 1/20 0.38
ADRA2A P08913 1/20 0.38
ADRA2B P18089 1/20 0.38
DRD1 P21728 1/20 0.38
DRD4 P21917 1/20 0.38
DRD5 P21918 1/20 0.38
ADRA1D P25100 1/20 0.38
HTR1D P28221 1/20 0.38
HTR1B P28222 1/20 0.38
HTR2C P28335 1/20 0.38
TSPO P30536 1/20 0.38
HTR7 P34969 1/20 0.38
ADRA1A P35348 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26399598 0.87 SIGMAR1 (0.48) SIGMAR1TACR1CHRM5CHRM2CHRM1
SCHEMBL12435283 0.87 SIGMAR1 (0.48) SIGMAR1TACR1CHRM5CHRM2CHRM1
SCHEMBL5223921 0.87 JAK2 (0.45) SIGMAR1TACR1CYP3A4CYP2D6CYP2C9
SCHEMBL5223918 0.87 JAK2 (0.45) SIGMAR1TACR1CYP3A4CYP2D6CYP2C9
SCHEMBL5223912 0.87 JAK2 (0.45) SIGMAR1TACR1CYP3A4CYP2D6CYP2C9
SCHEMBL4405607 0.78 SMN1; SMN2 (0.50) TACR1NPC1RAB9ASMN1; SMN2CYP3A4
SCHEMBL5259400 0.78 SMN1; SMN2 (0.50) TACR1NPC1RAB9ASMN1; SMN2CYP3A4
SCHEMBL5221088 0.77 TACR1 (0.48) TACR1CYP3A4CYP2D6CYP2C9
SCHEMBL26402882 0.74 PROKR1 (0.45)
SCHEMBL13949034 0.72 TACR1 (0.63) TACR1CYP3A4CYP2D6CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-RE48334-E1 Nitrogen-containing heterocyclic compound and use of same TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2020-12-01 US disclosed